CD
IBB icon

Chapin Davis’s iShares Biotechnology ETF IBB Stock Holding History

Chapin Davis’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$437K Hold
2,077
– – 0.08% 152
2026
Q2 		$395K Hold
2,077
– – 0.07% 167
2026
Q1 		$351K Hold
2,077
– – 0.08% 187
2025
Q4 		$351K Hold
2,077
– – 0.08% 176
2025
Q3 		$300K Sell
2,077
-70
-3% -$9.55K 0.07% 194
2025
Q2 		$272K Hold
2,147
– – 0.08% 185
2025
Q1 		$275K Sell
2,147
-118
-5% -$16K 0.09% 171
2024
Q4 		$330K Hold
2,265
– – 0.11% 163
2024
Q3 		$330K Buy
2,265
+340
+18% +$49.2K 0.11% 164
2024
Q2 		$264K Buy
1,925
+360
+23% +$48.1K 0.09% 181
2024
Q1 		$215K Buy
+1,565
New +$214K 0.08% 204

Other funds holding IBB

AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
CCA
Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
KIG
Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return

Chapin Davis's IBB Position: Q3 2026 in Review

Chapin Davis held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 2,077 shares worth $437K. The position accounts for 0.08% of the portfolio, ranked #152.

Chapin Davis first reported a position in IBB in Q1 2024 and has held it in 11 quarters since. 38 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Chapin Davis held 2,077 shares of iShares Biotechnology ETF worth $437K as of Q3 2026.
  • Chapin Davis left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.08% of Chapin Davis's portfolio in Q3 2026, its #152 holding.
  • Chapin Davis first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 11 quarters since.
  • 38 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Chapin Davis's 13F filing for Q3 2026, filed 9 Oct 2026.